MetaCap

Veradermics Incorporated Company Profile

NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

119.52-4.87 (-3.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Veradermics at a glance

Veradermics Incorporated (NYSE: MANE) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New Haven, CT. Veradermics is led by Dr. Reid Waldman M.D. and employs about 51 people. The company's shares have traded publicly since 2026.

At a market capitalization of $5.04 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001827635, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Veradermics do?

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.

Business description based on the company's public filings.

Company information

Legal name
Veradermics Incorporated
Ticker
NYSE: MANE
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Reid Waldman M.D.
Employees
51
Headquarters
470 James Street, New Haven, CT, United States
Phone
228 372 3376
IPO year
2026
SEC CIK
0001827635
Latest annual report
10-K · Mar 30, 2026

Companies similar to Veradermics

MANE peer companies
CompanyPrice% ChgMarket capCompare
BLTEBelite Bio Inc ADR127.38-15.65%$5.17Bvs MANE
LQDALiquidia Corporation54.43-3.88%$4.90Bvs MANE
ERASErasca Inc.13.61-4.29%$4.78Bvs MANE
DNTHDianthus Therapeutics Inc.84.55-0.33%$4.76Bvs MANE
PTCTPTC Therapeutics Inc.56.42-3.27%$4.71Bvs MANE
COGTCogent Biosciences Inc.26.72-3.69%$4.65Bvs MANE
GRFSGrifols S.A. ADR8.15-0.61%$5.55Bvs MANE
TVTXTravere Therapeutics Inc.47.00-2.69%$4.51Bvs MANE

Related